Human Immunodeficiency Virus (HIV) Drugs Market increasing demand with Leading key players: Bristol-Myers Squibb Company, ViiV Healthcare (Pfizer Inc.), Gilead Sciences Inc., Abbott Laboratories Inc.

Human Immune-deficiency Virus (HIV) is the most extensive and incurable disease, causes HIV infection and over time Acquired Immunodeficiency Syndrome (AIDS). There has been a significant rise in number of HIV population worldwide. According to the World Health Organization (WHO) 2013, HIV ranked 6th among the global deaths throughout the world, with approximately 1,776,270 deaths in 2009. HIV is the 2nd most common cause of death after cancer. According to the same reports in 2009, more than 1,780,000 global death case were filed. On the other side, surge in number of cases of infection transmission through infected blood and contaminated needles has been registered during past few years. For instance, according to WHO 2015, more than 150,000 HIV cases of infection due to contaminated needle were filed in India. Additionally, unprotected sex and breast milk by HIV infected mother are the most common route of HIV. This kind of infection affects a huge number of people across globally by decreasing the immunity of defence compared to infections.

Request for a free sample of this research report @ https://www.polarismarketresearch.com/industry-analysis/global-human-immunodeficiency-virus-hiv-drugs-market/request-for-free-sample

Increasing R&D in the area of HIV infection and growing demand for the drugs bolstering the HIV drugs market.

In the recent time, rising prevalence of HIV infection is on the huge surge. According to the World Health Organizations (WHO) 2015, globally around 37 million number of people were found to be infected with HIV. Thus, rising incidence of HIV infected people and the demand for the drugs to treat the disease are the major factors driving the global market. Additionally, Rise in the incidence of unprotected sex has led to increase in the prevalence of HIV/AIDS, further demanding cure drugs. Moreover, rising research and developments by the key players as well as investors to find the cure drugs for HIV infection and increasing government support for growing awareness regarding HIV and AIDS are further propelling HIV drugs market significantly.

On the basis of drug class, the global Human Immunodeficiency (HIV) drugs market is segmented into:

• Nucleoside reverse transcriptase inhibitors (NRTIs)
• Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs),
• Entry & Fusion Inhibitors
• Integrase Inhibitors
• Protease Inhibitors (PIs)
• Combination Class Drugs

On the basis of distribution channel, the global Human Immunodeficiency (HIV) drugs market is segmented into:

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others

Geographically, the global Human Immunodeficiency (HIV) drugs market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Make an inquiry for purchasing this report @ https://www.polarismarketresearch.com/industry-analysis/global-human-immunodeficiency-virus-hiv-drugs-market/inquire-before-buying

Key players in global Human Immunodeficiency (HIV) drugs market:

• Bristol-Myers Squibb Company
• ViiV Healthcare (Pfizer Inc.)
• GlaxoSmithKline plc
• Gilead Sciences Inc.
• Boehringer Ingelheim (C.H. Boehringer Sohn AG & Ko. KG)
• Hoffmann-La Roche AG
• Abbott Laboratories Inc.
• Janssen Therapeutics
• Merck & Co. Inc.
• Cipla Limited.

North America to dominate the global market owing to well-maintained healthcare infrastructure and growing awareness regarding the HIV infection.

Browse Full Report @ https://www.polarismarketresearch.com/industry-analysis/global-human-immunodeficiency-virus-hiv-drugs-market/

On the basis of geography, North America is the major dominating region in the global Human Immunodeficiency Virus (HIV) drugs market. The major market share in region is due to rising awareness about healthcare, well-established healthcare system, ample healthcare expenditure, rising government initiatives to control the spread of HIV, and higher HIV diagnosis & treatment rate. However, Asia-Pacific region is anticipated to grow with the highest share during forecast period, due to the presence large HIV patient pool, and ample growth opportunities in terms of unmet medical needs for management of HIV in the region. Moreover, increase in focus to find the possible cure for the infection & investment from key players in the region support the growth of the HIV drugs market in the Asia-Pacific region.

About us Polaris Market Research

Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities.

We mainly focus on aiding our customers with substantial competitive intelligence, helping them to secure a competitive advantage in the market and accomplish sustainable growth in different market domains. Adept with a highly competent, experienced and extremely qualified team of experts comprising SMEs, analysts and consultants, we at Polaris endeavor to deliver value-added business solutions to our customers. Through dedicated qualitative and quantitative primary and secondary market research and consulting assignments, we adeptly formulate competitive strategies to address business challenges for our clients through analyzing market trends and emerging technologies.

Contact us-

Mr. Neel
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com

This release was published on openPR.